State-dependent changes in high-frequency oscillations recorded in the rat nucleus accumbens.
Among the local field potentials recorded in the rat nucleus accumbens (NAc) spontaneous high frequency oscillations (HFO) are typically represented by a small peak in the power spectra in the range of 140-180 Hz. These HFO are known to occur in the awake state, but their distribution over the sleep-wake cycle has not been investigated. To address this issue we firstly examined the power of HFO during periods of quiet waking, slow-wave sleep (SWS) and rapid eye movement (REM) sleep. Since general anesthesia resembles certain features of naturally occurring SWS we went on to examine the effect of pentobarbital, isoflurane or urethane anesthesia on spontaneous and ketamine-induced increases in HFO. With respect to waking, the power of spontaneous HFO decreased significantly during periods of SWS but did not differ during bouts of REM sleep. General anesthetics also reduced the power of spontaneous HFO recorded in the NAc and prevented the ketamine-induced increase. These findings suggest that behavioural states where the generation of mental activity is most intense are associated with the presence of HFO in the NAc. In line with this, states which lead to decreased mentation, such as naturally occurring SWS and general anesthesia are associated with reductions in the power of HFO. Our results also suggest that the awake state is necessary for NMDA antagonists to produce enhancement of HFO.
Hunt
M J
MJ
Laboratory of the Limbic System, Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093 Warsaw, Poland. mhunt@nencki.gov.pl
Matulewicz
P
P
Gottesmann
C
C
Kasicki
S
S
D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D004567:Electrodes, Implanted; D004569:Electroencephalography; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D007530:Isoflurane / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology; D008297:Male; D008839:Microelectrodes; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000502:physiology*; D010424:Pentobarbital / Q000494:pharmacology; D010507:Periodicity; D051381:Rats; D017208:Rats, Wistar; D012894:Sleep Stages / Q000502:physiology*; D012895:Sleep, REM / Q000502:physiology*; D014520:Urethane / Q000494:pharmacology; D014851:Wakefulness / Q000502:physiology*
D000777:Anesthetics; D018691:Excitatory Amino Acid Antagonists; D014520:Urethane; D007649:Ketamine; D007530:Isoflurane; D010424:Pentobarbital